Your browser doesn't support javascript.
loading
The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells.
Wan, Lin-Yan; Peng, Hu; Ni, Yi-Ran; Jiang, Xue-Ping; Wang, Jiao-Jiao; Zhang, Yan-Qiong; Ma, Lan; Li, Rui; Han, Lin; Tan, Yong; Li, Jun-Ming; Cai, Wen-Li; Yuan, Wen-Fang; Liang, Jia-Jie; Huang, Lu; Wu, Xu; Zhou, Quan; Cheng, Qi-Ni; Yang, Xue; Liu, Meng-Yuan; Ai, Wen-Bing; Liu, Chang-Bai; Zhang, Hongbing; Wu, Jiang-Feng.
Afiliação
  • Wan LY; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences,
  • Peng H; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; Department of Surgery, The Yiling Hospital of Yichang, Yichang, China.
  • Ni YR; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Jiang XP; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; Department of Oncology II, The Central Hospital of Enshi Autonomous Prefecture, Enshi Clinical College of Wuhan U
  • Wang JJ; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China.
  • Zhang YQ; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Ma L; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences,
  • Li R; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Han L; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China.
  • Tan Y; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Li JM; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China.
  • Cai WL; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China.
  • Yuan WF; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Liang JJ; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Huang L; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Wu X; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China.
  • Zhou Q; Institute of Organ Fibrosis and Targeted Drug Delivery, The People's Hospital, China Three Gorges University, Yichang, China.
  • Cheng QN; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Yang X; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Liu MY; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Ai WB; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Department of Surgery, The Yiling Hospital of Yichang, Yichang, China.
  • Liu CB; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China.
  • Zhang H; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences,
  • Wu JF; Medical College, Yichang, China; Institute of Organ Fibrosis and Targeted Drug Delivery, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China; State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences,
Cell Mol Gastroenterol Hepatol ; 13(5): 1393-1412, 2022.
Article em En | MEDLINE | ID: mdl-35093591
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Células Estreladas do Fígado Limite: Animals / Humans Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Células Estreladas do Fígado Limite: Animals / Humans Idioma: En Revista: Cell Mol Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article